Impacts of Antibiotic-resistant Bacteria: Thanks to Penicillin-- He Will Come Home!. |
Other editions - View all
Common terms and phrases
acid active agents American ampicillin animals anti antibacterial antibi antibiotic resistance antibiotic-resistant bacteria Antimicrobial bacte bacterial cell bacterium biotics caused cephalosporins ciprofloxacin clinical coli companies costs currently diagnostic drug drug-resistant effective emergence and spread enzyme erythromycin fluoroquinolones Gram-negative growth guidelines hospital human immune increase infection control Infectious Diseases influenzae inhibit laboratory magainins membrane ment methicillin methods microbial Microbiology million MRSA mutations National nosocomial infections Office of Technology OPTION organisms otic-resistant otics otitis media outbreak pathogens patients penicillin percent phage therapy pharmaceutical physicians plasmids pneumoniae prescribe prevent produce prophylactic protein quinolones reduce resis resistance genes resistant bacteria risk scientists Semi-synthetic sequences SOURCE specific spread of antibiotic-resistant Staph Staphylococcus aureus strains Streptomyces subtherapeutic surveillance system susceptibility testing synthesis Technology Assessment teria tetracycline tion toxicity treat treatment tuberculosis United vaccine vancomycin York
Popular passages
Page 156 - have been neither proven nor disproven. The lack of data linking human illness with subtherapeutic levels of antimicrobials must not be equated with proof that the proposed hazards do not exist. The research necessary to establish and measure a definite risk has not been conducted, and, indeed may not be possible.
Page 175 - to the probability of benefit to individuals in a defined population from a medical technology applied for a given medical problem under defined conditions of use.
Page 87 - in journals such as The New England Journal of Medicine and The Journal of the American Medical Association
Page 125 - et al. 1978. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. Journal of Biological Chemistry
Page 156 - was unable to find a substantial body of direct evidence that established the existence of a definite human health hazard in the use of subtherapeutic concentrations of penicillin and the
Page 124 - BH Park, and SB Levy. 1994. Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria.
Page 90 - standardized specifications for care developed by a formal process that incorporates the best scientific evidence of effectiveness with expert opinion
Page iii - As with all OTA reports, the final responsibility for the content of the assessment rests with OTA.